UA100865C2 - Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины - Google Patents

Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины

Info

Publication number
UA100865C2
UA100865C2 UAA201006029A UAA201006029A UA100865C2 UA 100865 C2 UA100865 C2 UA 100865C2 UA A201006029 A UAA201006029 A UA A201006029A UA A201006029 A UAA201006029 A UA A201006029A UA 100865 C2 UA100865 C2 UA 100865C2
Authority
UA
Ukraine
Prior art keywords
heading
solid dispersion
dispersion product
normal
aryl urea
Prior art date
Application number
UAA201006029A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Рудольф Шредер
Танья Хайтерманн
Original Assignee
Эбботт Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эбботт Гмбх Унд Ко. Кг filed Critical Эбботт Гмбх Унд Ко. Кг
Publication of UA100865C2 publication Critical patent/UA100865C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
UAA201006029A 2007-10-19 2008-10-17 Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины UA100865C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99961807P 2007-10-19 2007-10-19
PCT/EP2008/064076 WO2009050291A2 (fr) 2007-10-19 2008-10-17 Produit de dispersion solide de médicaments de type n-aryle à base d'urée

Publications (1)

Publication Number Publication Date
UA100865C2 true UA100865C2 (ru) 2013-02-11

Family

ID=40089463

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201006029A UA100865C2 (ru) 2007-10-19 2008-10-17 Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины

Country Status (18)

Country Link
EP (1) EP2197425A2 (fr)
JP (1) JP2011500649A (fr)
KR (1) KR20100087170A (fr)
CN (1) CN101827584A (fr)
AU (1) AU2008313622A1 (fr)
BR (1) BRPI0818340A2 (fr)
CA (1) CA2699301A1 (fr)
CO (1) CO6270206A2 (fr)
CR (1) CR11442A (fr)
DO (1) DOP2010000117A (fr)
EC (1) ECSP10010183A (fr)
GT (1) GT201000102A (fr)
MX (1) MX2010004291A (fr)
PA (1) PA8800101A1 (fr)
RU (1) RU2010119929A (fr)
UA (1) UA100865C2 (fr)
WO (1) WO2009050291A2 (fr)
ZA (1) ZA201002095B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009100176A2 (fr) * 2008-02-07 2009-08-13 Abbott Laboratories Forme pharmaceutique pour administration orale d’un inhibiteur de tyrosine kinase
AR077975A1 (es) 2009-08-28 2011-10-05 Irm Llc Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
AU2011264993B2 (en) * 2010-06-09 2014-02-06 Abbvie Bahamas Ltd. Solid dispersions containing kinase inhibitors
CN108542906A (zh) 2011-11-11 2018-09-18 诺华股份有限公司 治疗增生性疾病的方法
JP6216325B2 (ja) * 2011-11-23 2017-10-18 ノバルティス アーゲー 医薬製剤
WO2014003678A1 (fr) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Compositions pharmaceutiques comprenant de l'ambrisentan et des particules de dispersion solide contenant du tadalafil
WO2014003677A1 (fr) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Compositions pharmaceutiques comprenant des particules de dispersion solide contenant du tadalafil

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101346128B (zh) * 2005-10-25 2013-10-02 雅培制药有限公司 包含低水溶解度药物的配方及其使用方法
WO2007066189A2 (fr) * 2005-12-09 2007-06-14 Pfizer Products Inc. Sels, promedicaments et formulations de 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-uree
CA2667720A1 (fr) * 2006-11-09 2008-05-15 Abbott Gmbh & Co. Kg. Forme de dosage pharmaceutique pour l'administration orale d'un inhibiteur de la tyrosine kinase

Also Published As

Publication number Publication date
CA2699301A1 (fr) 2009-04-23
ZA201002095B (en) 2011-11-30
CO6270206A2 (es) 2011-04-20
DOP2010000117A (es) 2010-05-15
KR20100087170A (ko) 2010-08-03
MX2010004291A (es) 2010-08-02
CN101827584A (zh) 2010-09-08
AU2008313622A1 (en) 2009-04-23
WO2009050291A3 (fr) 2010-04-08
JP2011500649A (ja) 2011-01-06
PA8800101A1 (es) 2009-05-15
WO2009050291A2 (fr) 2009-04-23
GT201000102A (es) 2012-03-12
EP2197425A2 (fr) 2010-06-23
BRPI0818340A2 (pt) 2015-04-22
ECSP10010183A (es) 2010-06-29
CR11442A (es) 2010-09-06
RU2010119929A (ru) 2011-11-27

Similar Documents

Publication Publication Date Title
MX2010004292A (es) Producto de dispersion solida que contiene un compuesto a base de n-aril urea.
UA100865C2 (ru) Твердый дисперсный продукт лекарственных средств на основе n-арилмочевины
TW200640502A (en) Tablets with improved drug substance dispersibility
WO2006035417A3 (fr) Preparations de dihydropyrimidine
TW200716202A (en) Pediatric formulation of topiramate
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2010015567A3 (fr) Formulations à libération contrôlée à l'aide de polymères intelligents
WO2009082152A3 (fr) Activateurs de la glucokinase et compositions pharmaceutiques contenant ces derniers en tant qu'ingrédient actif
PL2046292T3 (pl) Preparaty eterów benzymidazolilo-pirydylowych
MX2009010675A (es) Formulaciones farmaceuticas de moleculas de la hormona liberadora de la hormona delcrecimiento humana.
WO2009060952A1 (fr) Nouvelle préparation
NZ602441A (en) A fast dissolving pharmaceutical composition
WO2011076209A3 (fr) Composition pharmaceutique comprenant un mélange de solvants et un dérivé de la vitamine d ou analogue
WO2006110810A3 (fr) Polymorphes de di-n-methyle-d-glucamined'acide 3-o-(3',3'-dimethylsuccinyle) betulinique
WO2006127319A3 (fr) Formulations d'acide suberoylanilide hydroxamique et leurs procedes de production
WO2007065625A3 (fr) Compositions pharmaceutiques a base d'agents hypnotiques de courte duree d’action, disponibles sous formes a liberation modifiee, et procedes de preparation desdites formulations
WO2008084864A1 (fr) Activateur du récepteur de la capsaïcine et appareil pour le pulvériser
WO2009008004A3 (fr) Formulations à libération prolongée de divalproex de sodium
WO2010058104A3 (fr) Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation
WO2008122425A3 (fr) Compositions orales contenant du tacrolimus sous forme amorphe
WO2009150530A3 (fr) Nouvelle composition de mousse
WO2008105392A1 (fr) Dérivé de 3-amino-2-indolyl-butyrolactame, son procédé de production et agent pharmaceutique le comprenant en tant que principe actif
TH104743B (th) ผลิตภัณฑ์แพร่กระจายแข็งที่มีสารประกอบ n-อะริล ยูเรีย
WO2011154830A3 (fr) Forme pharmaceutique d'inhibiteurs de la phosphodiestérase pour l'adminsitration par voie transmucosale
TH104743A (th) ผลิตภัณฑ์แพร่กระจายแข็งที่มีสารประกอบ n-อะริล ยูเรีย